Human study · Aging · 23 Sept 2026
Menopause blood markers tracked brain aging and later dementia risk in women
Source: News-Medical / Nature journal
What the research found
Study (observational). Alexander and colleagues report in a Nature journal (doi 10.1038/s41591-026-04648-4; News-Medical 23 September 2026) that a menopause score built from 16 circulating markers rose from premenopause to postmenopause in 80 women aged 43–58 (30 pre, 26 peri, 24 post), more tightly with menopause stage and FSH than with age. Thirty-six age-matched men did not show that age link. In 2,814 UK Biobank women aged 45–60, nine of 13 compared markers replicated. Postmenopausal women of the same age had less favorable proteomic organ-aging estimates, including brain and artery. In 89 women averaging about 69, higher scores tracked a history of hot flashes, sleep problems, and more menopause symptoms. In later-life cohorts with mean ages about 61 to 72, higher scores tracked less favorable cognitive change in ADNI and BrANCH, lower cross-sectional cognition in WRAP, and a higher risk of incident Alzheimer dementia in UK Biobank, not all-cause, vascular, or frontotemporal dementia. Small discovery sample, cross-sectional start, self-reported symptoms. Association, not proof that menopause markers cause dementia. Educational aging notes.
Evidence level: Human study. A study in people, but an association isn't proof of cause.
More aging news
- In middle-aged male mice, an earlier loss of new tumor-fighting immune cells lined up with weaker melanoma control
- A commentary says telomere RNA loops can stall DNA copying and, in some tumors, get used to keep chromosome ends going
- After a long decline, heart-valve death rates in U.S. older adults rose from 2018 to 2023
- In adults over 50 followed for 24 years, a higher body mass index lined up with a faster drop in memory and thinking
- A lab force on bone extended lifespan in older mice through a signal called PEDF